SOURCE: Industrial Info Resources

Industrial Info Resources

November 18, 2011 06:20 ET

Flu Season Gives Big Pharma $3.5 Billion Shot in Fiscal Arm, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - Nov 18, 2011) - Researched by Industrial Info Resources (Sugar Land, Texas) -- The end of the year brings the holiday season and festivities, but it also marks the start of the influenza season and another round of flu shots. Worldwide, seasonal influenza kills an estimated 250,000 to 500,000 people each year. Tens of thousands of Americans die in a typical flu season. Governments and pharmaceutical companies have been preparing for flu season since the beginning of the year to ensure there are enough stockpiles of the flu vaccines to protect the population.

Currently, six pharmaceutical companies are licensed to produce the influenza vaccine, including Sanofi Pasteur, the vaccines division of Sanofi SA (NYSE:SNY); Novartis AG (NYSE:NVS) (Basel, Switzerland); GlaxoSmithKline (NYSE:GSK) (London, England); ID Biomedical Corporation of Quebec (Laval, Quebec), a subsidiary of GlaxoSmithKline; CSL Biotherapies (Victoria, Australia); and MedImmune LLC (Gaithersburg, Maryland).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Joe Govreau